                               SEQUENCE LISTING

<110> ONESKIN, INC.
      UNIAO BRASILEIRA DE EDUCACAO CATOLICA
      UNIVERSIDADE CATOLICA DE BRASILIA
 
<120> POLYPEPTIDES HAVING ANTI-INFLAMMATORY EFFECTS AND USES THEREOF

<130> 56292-705.601

<140> PCT/US2021/057630
<141> 2021-11-01

<150> 63/108,866
<151> 2020-11-02

<160> 43    

<170> PatentIn version 3.5

<210> 1
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Glu Thr Ala Lys His Trp Leu Lys Gly Ile 
1               5                   10  


<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Ala Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Lys Leu Lys Gly Ile Leu Arg Gly Ala Ala 
1               5                   10  


<210> 4
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Trp Leu Lys Gly Ile Leu Arg Glu Ala Ala 
1               5                   10  


<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Leu Lys Gly Ile 
1               


<210> 6
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Leu Lys Gly Ile Leu 
1               5   


<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Trp Leu Lys Gly Ile 
1               5   


<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid except Ser

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 8
Glu Thr Xaa Lys Xaa Trp Leu Xaa Gly Ile 
1               5                   10  


<210> 9
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Ser Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Glu Thr Ala Lys Ala Trp Glu Lys Gly Ile 
1               5                   10  


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Glu Thr Ala Lys Ala Trp His Lys Gly Ile 
1               5                   10  


<210> 12
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Glu Thr Ala Lys Ala Trp Leu Lys Ser Ile 
1               5                   10  


<210> 13
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Glu Thr Ala Lys Ala Trp Leu Lys Gly Glu 
1               5                   10  


<210> 14
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Glu Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 15
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Trp Leu Lys Gly Ile Leu Arg Gly Ala Ala 
1               5                   10  


<210> 16
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Lys Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 17
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Asn Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 18
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Pro Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Gln Thr Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Glu Gln Ala Lys Ala Trp Leu Lys Gly Ile 
1               5                   10  


<210> 21
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Trp Leu Lys Gly Ile Cys Arg Gly Ala Ala 
1               5                   10  


<210> 22
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Trp Leu Lys Gly Ile Leu Pro Gly Ala Ala 
1               5                   10  


<210> 23
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Trp Leu Lys Gly Ile Leu Gln Gly Ala Ala 
1               5                   10  


<210> 24
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Trp Leu Lys Gly Ile Leu Ser Gly Ala Ala 
1               5                   10  


<210> 25
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Trp Leu Lys Gly Ile Leu Val Gly Ala Ala 
1               5                   10  


<210> 26
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Trp Leu Lys Gly Ile Leu Arg Ala Ala Ala 
1               5                   10  


<210> 27
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Trp Leu Lys Gly Ile Leu Arg Gly His Ala 
1               5                   10  


<210> 28
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Trp Leu Lys Gly Ile Leu Arg Gly Ile Ala 
1               5                   10  


<210> 29
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid except Gly

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 29
Glu Thr Xaa Lys Xaa Trp Leu Xaa Gly Ile 
1               5                   10  


<210> 30
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid except Asn

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 30
Glu Thr Xaa Lys Xaa Trp Leu Xaa Gly Ile 
1               5                   10  


<210> 31
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid except Asn

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 31
Lys Leu Xaa Xaa Ile Leu Xaa Gly Xaa Ala 
1               5                   10  


<210> 32
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid except Ser

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 32
Lys Leu Xaa Xaa Ile Leu Xaa Gly Xaa Ala 
1               5                   10  


<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid except Leu

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 33
Lys Leu Xaa Xaa Ile Leu Xaa Gly Xaa Ala 
1               5                   10  


<210> 34
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid except Ser

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 34
Lys Leu Xaa Xaa Ile Leu Xaa Gly Xaa Ala 
1               5                   10  


<210> 35
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 35
ccgcggttag cgctag                                                       16


<210> 36
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 36
ttataaccga tatcga                                                       16


<210> 37
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 37
ggacttggcg cagacg                                                       16


<210> 38
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 38
aagtccaata tgagta                                                       16


<210> 39
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 39
atccactgag gtgcgt                                                       16


<210> 40
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 40
gcttgtcaga acatac                                                       16


<210> 41
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 41
caagctagac atagcg                                                       16


<210> 42
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 42
tggatcgagt gcgata                                                       16


<210> 43
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 43
agttcaggcc aacaga                                                       16


